Product Information
AUSTEDO 6 MG TABLET is a brand product labeled by Teva Neuroscience, Inc., priced at $83.2000 per EA under NDC 68546017060. Its NADAC has been published 368 times since Sep 18, 2019.
FDA first approved this application on Apr 3, 2017.
Strength
6 mg/1
Manufacturer
Teva Neuroscience, Inc.NDC
68546017060
Classification
Brand
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DEUTETRABENAZINEApproval Type
New Drug (NDA)
FDA Application
NDA208082FDA Approved
4/3/2017
On Market Since
4/12/2017
Price Statistics
The NADAC for AUSTEDO 6 MG TABLET has been published 368 times since Sep 18, 2019, and over the history we have for it it has risen 41.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $83.2000 per EA |
|---|---|
| All-time high | $83.5114 (May 13, 2026) |
| All-time low | $58.2012 (Nov 20, 2019) |
| 52-week high | $83.5114 |
| 52-week low | $79.1511 |
| Median price | $75.4773 |
| Average price | $72.3464 |
| Largest weekly change | +7.9% (Jan 12, 2022) |
| Weeks tracked | 368 |
| Tracking since | Sep 18, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Deutetrabenazine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Neuroscience, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Deutetrabenazine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AUSTEDO 6 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AUSTEDO 6 MG TABLET, manufactured by Teva Neuroscience, Inc., is $83.2000 per EA (NDC 68546017060), effective Sep 30, 2026.
How has the price of AUSTEDO 6 MG TABLET changed over time?
Over the history we have for it, the NADAC for AUSTEDO 6 MG TABLET has risen 41.4%. It has been tracked across 368 weekly CMS publications since Sep 18, 2019.
What are the highest and lowest recorded NADAC prices for AUSTEDO 6 MG TABLET?
Since Sep 18, 2019, the NADAC for AUSTEDO 6 MG TABLET has ranged from a low of $58.2012 (Nov 20, 2019) to a high of $83.5114 (May 13, 2026), with a median of $75.4773 per EA.
Are there cheaper alternatives to AUSTEDO 6 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of AUSTEDO 6 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AUSTEDO 6 MG TABLET?
AUSTEDO 6 MG TABLET (NDC 68546017060) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.